Bone marrow aspirate clot: A feasible orthobiologic

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biotechnology

Background:

• Musculoskeletal disorders represent a significant global health burden, causing disability and impacting quality of life.
• Current treatments for musculoskeletal injuries offer limited efficacy, primarily providing short-term pain relief without tissue restoration.
• Orthobiologics, including bone marrow aspirate (BMA) clot, are emerging as promising alternatives for musculoskeletal tissue repair.

Purpose of the Study:

• To review the therapeutic potential of bone marrow aspirate (BMA) clot in musculoskeletal regeneration.
• To explore the cellular and molecular components of BMA and their roles in tissue repair.
• To discuss the immunomodulatory and paracrine functions of stem cells within BMA for treating musculoskeletal injuries.

Main Methods:

• Literature review of studies investigating bone marrow aspirate (BMA) clot for musculoskeletal injuries.
• Analysis of in vitro and in vivo models demonstrating the regenerative effects of BMA.
• Examination of the mechanisms underlying BMA's role in tissue repair, including stem cell activity and fibrinolysis.

Main Results:

• Bone marrow aspirate (BMA) contains hematopoietic and mesenchymal stem cells with regenerative capabilities.
• BMA components demonstrate positive effects on tissue regeneration in various experimental models.
• Stem cells in BMA exhibit immunomodulatory and paracrine functions crucial for inflammatory response and tissue repair.

Conclusions:

• Bone marrow aspirate (BMA) clot represents a promising orthobiologic treatment for musculoskeletal disorders.
• The regenerative potential of BMA stems from its rich cellular and molecular constituents, particularly stem cells.
• Further research is needed to fully elucidate the complex regenerative mechanisms of BMA for optimizing therapeutic applications.